{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:28:13Z","timestamp":1766158093329,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jfma.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T13:16:10Z","timestamp":1504530970000},"page":"566-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hepatitis B virus-related mortality in rheumatoid arthritis patients undergoing long-term low-dose glucocorticoid treatment: A population-based study"],"prefix":"10.1016","volume":"117","author":[{"given":"Sheng-Shun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8449-5298","authenticated-orcid":false,"given":"Chin-Tun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horng-Mo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Chin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7304-4587","authenticated-orcid":false,"given":"Hsin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Chuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jfma.2017.07.004_bib1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.jfma.2017.07.004_bib2","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"issue":"3","key":"10.1016\/j.jfma.2017.07.004_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2013.06.001","article-title":"Sex-and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study","volume":"43","author":"See","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jfma.2017.07.004_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3 Suppl. 66","key":"10.1016\/j.jfma.2017.07.004_bib5","first-page":"S15","article-title":"Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety","volume":"29","author":"Favalli","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.jfma.2017.07.004_bib6","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/art.21421","article-title":"Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial","volume":"52","author":"Wassenberg","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl.","key":"10.1016\/j.jfma.2017.07.004_bib7","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1590\/S0021-75572007000700007","article-title":"Glucocorticoid therapy: minimizing side effects","volume":"83","author":"Longui","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jfma.2017.07.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2004.10.003","article-title":"Developments in glucocorticoid therapy","volume":"31","author":"Bijlsma","year":"2005","journal-title":"Rheum Dis Clin N. Am"},{"issue":"5 Suppl. 68","key":"10.1016\/j.jfma.2017.07.004_bib9","first-page":"S81","article-title":"Glucocorticoids in rheumatology: indications and routes of administration","volume":"29","author":"Jacobs","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"5 Suppl. 68","key":"10.1016\/j.jfma.2017.07.004_bib10","first-page":"S13","article-title":"Pharmacodynamics of glucocorticoids","volume":"29","author":"Strehl","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jfma.2017.07.004_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.jfma.2017.07.004_bib12","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/art.21298","article-title":"Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial","volume":"52","author":"Svensson","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jfma.2017.07.004_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcma.2012.06.006","article-title":"Management of chemotherapy-induced hepatitis B virus reactivation","volume":"75","author":"Huang","year":"2012","journal-title":"J Chin Med Assoc"},{"issue":"9401","key":"10.1016\/j.jfma.2017.07.004_bib14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(03)15108-2","article-title":"Viral hepatitis B","volume":"362","author":"Lai","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jfma.2017.07.004_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1756-185X.12154","article-title":"Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs","volume":"16","author":"Lee","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.jfma.2017.07.004_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1440-1746.2012.07280.x","article-title":"Hepatitis B virus reactivation associated with anti-neoplastic therapy","volume":"28","author":"Yeo","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2017.07.004_bib17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","article-title":"Hepatitis B virus DNA contains a glucocorticoid-responsive element","volume":"83","author":"Tur-Kaspa","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.jfma.2017.07.004_bib18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199504063321401","article-title":"Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up","volume":"332","author":"Bonadonna","year":"1995","journal-title":"N. Engl J Med"},{"issue":"4","key":"10.1016\/j.jfma.2017.07.004_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmv.10430","article-title":"Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study","volume":"70","author":"Yeo","year":"2003","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.jfma.2017.07.004_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.jfma.2017.07.004_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3350\/cmh.2012.18.2.225","article-title":"A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier","volume":"18","author":"Bae","year":"2012","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10.1016\/j.jfma.2017.07.004_bib22","first-page":"297","article-title":"Update on the use of steroids in rheumatoid arthritis","volume":"9","author":"Garcia-Magallon","year":"2013","journal-title":"Reumatol Clin"},{"issue":"2","key":"10.1016\/j.jfma.2017.07.004_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.47102\/annals-acadmedsg.V36N2p100","article-title":"Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases","volume":"36","author":"Thong","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jfma.2017.07.004_bib24","article-title":"Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs","author":"Nakamura","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"10.1016\/j.jfma.2017.07.004_bib25","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1136\/ard.2010.148783","article-title":"Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy","volume":"70","author":"Lan","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617300086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617300086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:58:48Z","timestamp":1692964728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664617300086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0929664617300086"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2017.07.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus-related mortality in rheumatoid arthritis patients undergoing long-term low-dose glucocorticoid treatment: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}